[EN] KRAS G12C INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE KRAS G12C ET LEURS UTILISATIONS
申请人:CALIFORNIA INST OF TECHN
公开号:WO2022115439A1
公开(公告)日:2022-06-02
The invention relates to compounds of Formula I, and pharmaceutically acceptable salts thereof, and methods of making and using the same. The compounds of the invention are effective in inhibiting KRAS protein with a G12C mutation and are suitable for use in methods of treating cancers mediated, in whole or in part, by KRAS G12C mutation.
本发明涉及公式I的化合物及其药学上可接受的盐,以及其制备和使用方法。本发明的化合物能够有效地抑制带有G12C突变的KRAS蛋白,并适用于治疗完全或部分介导KRAS G12C突变的癌症的方法。